{"id":"NCT04964544","sponsor":"AstraZeneca","briefTitle":"Technology-Assisted Cholesterol Trial in Consumers (TACTiC)","officialTitle":"A Phase III, 6-Month Self-selection and Actual Use Study for Rx-to-OTC Switch of Rosuvastatin 5 mg Once-daily in Combination With a Web App","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-07-08","primaryCompletion":"2023-03-01","completion":"2023-03-01","firstPosted":"2021-07-16","resultsPosted":"2024-10-30","lastUpdate":"2024-10-30"},"enrollment":1196,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["High Cholesterol"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"5 mg rosuvastatin calcium with a Web App (combination product)","otherNames":["Crestor 5 mg"]}],"arms":[{"label":"Open Label, Single Arm Technology-Assisted Cholesterol Trial","type":"OTHER"}],"summary":"The purpose of this AUS is to evaluate the extent to which participants can safely and effectively self-select, purchase, and use Crestor OTC 5 mg for a 6-month period according to the label.","primaryOutcome":{"measure":"Overall Correct Initial TASS Outcome, Worst Case Imputation, First Co-Primary Endpoint (Self-Selection Population)","timeFrame":"Study day -30 to -1, at initial TASS assessment","effectByArm":[{"arm":"Nonprescription Rosuvastatin","deltaMin":1085,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["18335281","8349060","30586774","38599257"],"seeAlso":["http://lowercholesterol.study","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D356PL00015&amp;attachmentIdentifier=c0a32e33-61a7-46a8-9711-1dc23e122ebb&amp;fileName=redacted_CSP.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D356PL00015&amp;attachmentIdentifier=a51da88d-0773-4001-b444-d89a9aab4c08&amp;fileName=redacted_SAP.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D356PL00015&amp;attachmentIdentifier=bad1de2a-9917-447a-aabd-2dd5c5bf45e7&amp;fileName=redacted_CSR_Synopsis.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":27,"n":1177},"commonTop":["Sars-cov-2 test positive","Arthralgia","Headache","Pain in extremity","Cough"]}}